Smartleaf Asset Management
NVCR icon

Smartleaf Asset Management’s NovoCure NVCR Stock Holding History

Smartleaf Asset Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.01K Buy
501
+93
+23% +$1.55K ﹤0.01% 2523
2026
Q2 		$6.32K Hold
408
– – ﹤0.01% 2588
2026
Q1 		$4.23K Sell
408
-67
-14% -$837 ﹤0.01% 2732
2025
Q4 		$6.28K Buy
475
+268
+129% +$3.44K ﹤0.01% 2609
2025
Q3 		$2.67K Buy
207
+178
+614% +$2.38K ﹤0.01% 2537
2025
Q2 		$522 Sell
29
-224
-89% -$3.9K ﹤0.01% 2580
2025
Q1 		$4.77K Buy
253
+69
+38% +$1.57K ﹤0.01% 2202
2024
Q4 		$5.53K Sell
184
-155
-46% -$3.28K ﹤0.01% 2214
2024
Q3 		$5.29K Buy
339
+252
+290% +$4.57K ﹤0.01% 2094
2024
Q2 		$1.53K Buy
87
+36
+71% +$633 ﹤0.01% 2314
2024
Q1 		$746 Buy
+51
New +$750 ﹤0.01% 1675

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Quantinno Capital Management
Quantinno Capital Management New York $106B AUM 29.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
C WorldWide Group
C WorldWide Group Copenhagen, Denmark $3.96B AUM 10.41% 1-Year Est. Return

Smartleaf Asset Management's NVCR Position: Q3 2026 in Review

Smartleaf Asset Management increased its NovoCure (NVCR) stake by 23% in Q3 2026, buying an estimated $1.55K and bringing the position to 501 shares worth $8.01K. The position accounts for ﹤0.01% of the portfolio, ranked #2523.

Smartleaf Asset Management first reported a position in NVCR in Q1 2024 and has held it in 11 quarters since. 160 funds tracked by Wall St. Rank hold NVCR as of Q3 2026.

  • Smartleaf Asset Management held 501 shares of NovoCure worth $8.01K as of Q3 2026.
  • Smartleaf Asset Management bought 93 NovoCure shares in Q3 2026, an estimated $1.55K.
  • NovoCure made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #2523 holding.
  • Smartleaf Asset Management first reported a position in NovoCure in Q1 2024 and has held it in 11 quarters since.
  • 160 funds tracked by Wall St. Rank held NovoCure as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.